FundingWatcher
Home / Startups / Top biotech startups / Biotech startups that raised Series B / Biotech startups that raised Series B in South Korea

Biotech startups that raised Series B in South Korea

Updated 16 Nov 2026

Reset
Biotech startups that raised Series B in South Korea
One-time CSV
  • 75 funded companies, 60 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech--series-b~south-korea.csv75 rows × 18 columns
CompanyCityLast roundAmountDate
HITSSeoulSeries B$13.5M2026-09-28
GaluxDogokdongSeries B$29.0M2026-02-09
LN RoboticsHanamSeries B$14.5M2024-07-09
Avelos TherapeuticsSeoulSeries B$12.4M2024-05-02
SurginexSeochoSeries B$6.3M2024-03-28
NeoCannBioSeoulSeries B$7.4M2023-09-26
DeargenDaejeonSeries B$16.6M2022-02-24
Cell Lab MedSeoulSeries B$19.7M2021-11-15

8 rows of the CSV in 5 of its 18 columns.

75
Startups
$645.5M
Total raised
6
Funded in the last 12 months
$88.4M
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

7 of 75
Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
HITS HITS develops artificial intelligence software for drug discovery and pharmaceutical research. Artificial intelligence Seoul Series B $13.5M 2026-09-28 $25.1M Korea Investment Partners, Capstone Partners, Company K Partners +2 11 to 50 2020
Galux Galux designs molecules to discover new drugs for incurable and rare diseases. Artificial intelligence Dogokdong Series B $29.0M 2026-02-09 $36.3M Dayli Partners 11 to 50 2020
LN Robotics LN Robotics is a technology research firm that develops medical robots. Biotech Hanam Series B $14.5M 2024-07-09 $21.3M TIPS Program, Bluepoint, Mirae Asset Venture Investment +2 11 to 50 2019
Surginex Surginex develops biological drugs and offers molecular biology, genetics, and physical and chemical analysis services. Biotech Seocho Series B $6.3M 2024-03-28 Hana Ventures, Laguna Investment, Partners Investment +1 1 to 10 2020
Plcoskin Plcoskin is a MedTech company that offers reconstructive plastic surgery and regenerative skincare. Biotech Seoul Series B $4.5M 2023-08-31 TIPS Program, Primer, We Ventures +1 11 to 50 2018
Deargen Deargen provides AI-based genome analysis services. Artificial intelligence Daejeon Series B $16.6M 2022-02-24 TIPS Program, Hana Ventures, The Wells Investment 51 to 100 2016
PharmCADD PharmCADD uses AI protein structure prediction, molecular dynamics, and quantum calculations to speed drug design. Artificial intelligence Busan Series B $16.0M 2021-04-19 DSC Investment, KB Securities, KDB Capital +1 51 to 100 2019

Table 1. Biotech startups that raised Series B in South Korea: the 7 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 75.

Largest rounds

Last 12 months
# Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
1 Galux Galux designs molecules to discover new drugs for incurable and rare diseases. Artificial intelligence Dogokdong Series B $29.0M 2026-02-09 $36.3M Dayli Partners 11 to 50 2020
2 HITS HITS develops artificial intelligence software for drug discovery and pharmaceutical research. Artificial intelligence Seoul Series B $13.5M 2026-09-28 $25.1M Korea Investment Partners, Capstone Partners, Company K Partners +2 11 to 50 2020

Table 2. Biotech startups that raised Series B in South Korea: the 2 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 TIPS Program Startup incubator Gangneung, South Korea 3 4%
2 Kiwoom Investment Venture capital firm Youidodong, South Korea 2 3% 1 HITS
3 STIC Ventures Venture capital firm Seoul, South Korea 2 3% 1 HITS
4 Korea Investment Partners Private equity firm Seoul, South Korea 2 3% 1 HITS
5 Mirae Asset Venture Investment Venture capital firm Seongnam, South Korea 2 3%
6 Mirae Asset Capital Investment bank Seoul, South Korea 2 3%
7 Hana Ventures Corporate venture arm Seoul, South Korea 2 3%
8 Capstone Partners Venture capital firm Seoul, South Korea 1 1% 1 HITS
9 Company K Partners Venture capital firm Ilsangu, South Korea 1 1% 1 HITS
10 Dayli Partners Venture capital firm Seoul, South Korea 1 1% 1 Galux
11 Bluepoint Startup accelerator Daejeon, South Korea 1 1%
12 UTC Investment Co. Venture capital firm Seoul, South Korea 1 1%
13 SV Investment Corp Venture capital firm Seoul, South Korea 1 1%
14 Partners Investment Venture capital firm Seoul, South Korea 1 1%
15 Laguna Investment Venture capital firm Seoul, South Korea 1 1%

Table 3. Biotech startups that raised Series B in South Korea: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 66 88% $631.3M
Software 8 11% $96.2M
Artificial intelligence 5 7% $61.4M
Hardware 4 5% $45.3M
Cybersecurity 1 1%

Table 4. Biotech startups that raised Series B in South Korea by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Series B 75 100% $10.4M

Table 5. Biotech startups that raised Series B in South Korea by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
Seoul 25 33%
Seongnam 11 15%
Daejeon 4 5%
Pohang 3 4%
Songpadong 3 4%
Seocho 2 3%
Suwon 2 3%
Jungang 1 1%
Dogokdong 1 1%
Jeonju 1 1%
Hanam 1 1%
Gwangju 1 1%

Table 6. Biotech startups that raised Series B in South Korea by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
September 2026 3 50% $35.6M
June 2026 1 17% $14.0M
February 2026 1 17% $29.0M
December 2025 1 17% $9.9M

Table 7. Biotech startups that raised Series B in South Korea: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 5 7% $78.6M
2025 6 8% $85.1M
2024 7 9% $49.4M
2023 11 15% $90.2M
2022 20 27% $284.6M
2021 11 15% $163.1M

Table 8. Biotech startups that raised Series B in South Korea by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2020 to 2022 14 19%
2015 to 2019 48 64%
2010 to 2014 7 9%
Before 2010 6 8%

Table 9. Biotech startups that raised Series B in South Korea by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 12 17%
11 to 50 44 63%
51 to 100 12 17%
101 to 250 2 3%

Table 10. Biotech startups that raised Series B in South Korea by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in South Korea whose last round is Series B are on the list?
75, in the file dated 16 November 2026. 6 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 75 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups that raised Series B in South Korea: 75 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech at other stages in South Korea

Other sectors that raised Series B in South Korea

Cite: FundingWatcher, 75 biotech companies in South Korea whose most recent round is Series B, 16 November 2026. https://fundingwatcher.com/startups/biotech/series-b/south-korea/